| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |